$32 Mil. Charge For Accounting Problem Not Sign Of “Material Weakness,” Cardinal Says
This article was originally published in The Pink Sheet Daily
Improperly booked vendor credits that necessitated a $32 mil. charge in Cardinal's pharmaceutical distribution business do not reflect a "material weakness," the company said
You may also be interested in...
The wholesaler delays fiscal 2004 10-K filing after an audit committee concludes the last three years of reports will need to be restated. Cardinal predicts 10%-15% earnings decline in first half of fiscal 2005.
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said